The failure of IGF-1R-pathway blocking therapeutics in the oncology space has been the subject of much handwringing [65,66,67,68,69,70,71], as well as research into the causes underlying clinical failure of agents that showed pre-clinical promise
Diabetes Ther Res Treat Educ Diabetes Rel Disorders
Joint Health BPC-157 may help support healthy joints and the tissues surrounding them
Females have two X chromosomes, hence two copies of G6PD, while males have only one X-chromosome and one copy of G6PD
MYDAWA is Back in Bloom - Your favourite health & wellness essentials are all available, at lower everyday prices
Weight gain after stopping GLP-1 drugs (by Patricia Toro, MD MPH) November 21, 2023 This post guest-authored by my colleague Patricia Toro, MD MPH Source: Rubino, et al JAMA March, 2021 LINK The GLP-1 drug class has been shown to be effective at supporting weight loss, from an average of 15% for Wegovy (semaglutide) to 21% for the newly- approved Zepbound (tirzepatide)